Literature DB >> 22289732

Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab.

Ilaria Puxeddu, Lucia Giori, Valeria Rocchi, Laura Bazzichi, Stefano Bombardieri, Antonio Tavoni, Paola Migliorini, Isabella Del Corso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22289732     DOI： 10.1016/j.anai.2011.11.004

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  9 in total

1.  Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis.

Authors:  Huifeng Yun; Fenglong Xie; Randall N Beyl; Lang Chen; James D Lewis; Kenneth G Saag; Jeffrey R Curtis
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-10       Impact factor: 4.794

2.  Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years' experience of a tertiary pediatric rheumatology center.

Authors:  Rahime Koç; Hafize Emine Sönmez; Mustafa Çakan; Şerife Gül Karadağ; Ayşe Tanatar; Figen Çakmak; Nuray Aktay Ayaz
Journal:  Rheumatol Int       Date:  2019-12-21       Impact factor: 2.631

Review 3.  Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.228

4.  Systemic adalimumab induces peripheral corneal infiltrates: a case report.

Authors:  Alexandre Matet; Alejandra Daruich; Talal Beydoun; Jacques Cosnes; Jean-Louis Bourges
Journal:  BMC Ophthalmol       Date:  2015-06-06       Impact factor: 2.209

Review 5.  Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers.

Authors:  Teodorikez Wilfox Jimenez-Rodriguez; Marlene Garcia-Neuer; Leila A Alenazy; Mariana Castells
Journal:  J Asthma Allergy       Date:  2018-06-20

6.  Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions.

Authors:  Grzegorz Porebski; Kamila Kwiecien; Magdalena Pawica; Mateusz Kwitniewski
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

Review 7.  Hypersensitivity Reactions to Monoclonal Antibodies in Children.

Authors:  Francesca Mori; Francesca Saretta; Annamaria Bianchi; Giuseppe Crisafulli; Silvia Caimmi; Lucia Liotti; Paolo Bottau; Fabrizio Franceschini; Claudia Paglialunga; Giampaolo Ricci; Angelica Santoro; Carlo Caffarelli
Journal:  Medicina (Kaunas)       Date:  2020-05-12       Impact factor: 2.430

Review 8.  Hypersensitivity and Immune-related Adverse Events in Biologic Therapy.

Authors:  Jamie L Waldron; Stephen A Schworer; Mildred Kwan
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-28       Impact factor: 8.667

9. 

Authors:  Askin Gülsen; Bettina Wedi; Uta Jappe
Journal:  Allergo J       Date:  2020-06-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.